| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0063 | 0.9 |